SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)

Clinical trials for SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0) explained in plain language.

Never miss a new study

Get alerted when new SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0) trials appear

Sign up with your email to follow new studies for SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2

One-Time gene edit aims to cure devastating blood diseases

⭐️ CURE ⭐️ Recruiting now

This early-stage trial is testing a one-time gene editing treatment for people with severe sickle cell disease or beta-thalassemia. Doctors take a patient's own blood stem cells, edit a specific gene to boost healthy fetal hemoglobin, and return the cells after chemotherapy. The …

Matched conditions: SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)

Phase: PHASE1 • Sponsor: Daniel Bauer • Aim: ⭐️ CURE ⭐️

Last updated Mar 27, 2026 12:38 UTC

SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)

Get alerted when new SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0) trials appear

One-Time gene edit aims to cure devastating blood diseases